Invasives Aspergillosis in Acute Myeloid Leukemia

• Status: Completed
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients with acute myeloid leukemia (AML) are at risk to develop severe infections whose invasive aspergillosis (IA). These infections are leading to an important morbidity and mortality. Antifungal prophylaxis is recommended by posaconazole for AML patients during neutropenia induced by induction chemotherapy. Their application is not uniform.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Brest
• Treatments: Antifungal Agents; Clotrimazole; Miconazole

Criteria

Inclusion Criteria:

• > 18 years

• acute myeloid leukemia

• intensive chemotherapy (induction, consolidation, salvage, bone marrow transplantation)

Exclusion Criteria:

• < 18 years

• pregnancy

• no intensive chemotherapy (palliative treatment, azacytidine...)